课题基金 / 基金详情

Basic Research on the Development of Recombinant Vaccines for Animals by Genetic Engineering

Basic Research on the Development of Recombinant Vaccines for Animals by Genetic Engineering
利用基因工程开发动物重组疫苗的基础研究
批准号:
62440019
负责人:
SATO Fumiaki
金额:
$17.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1990

项目摘要

项目成果

SATO Fumiaki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this research project is to get basic data to develop recombinant vaccines for veterinarians. Recombinant vaccines consisted of two components, vector virus and antigen genes. In this study, we used two viruses which can be used for vector of recombinant vaccines. One is herpesvirus of turkeys which is used as a vaccine of Marek's disease virus and the other is fowl pox virus. We decided thymidine kinase gene as a marker for genetic recombination between the vector virus gnome and antigen gene. And hemagglutinin-neuraminidase gene of Newcastle disease virus was cloned into thymidine kinase site of fowl pox virus. Mutations of the antigen genes of influenza virus and Newcastle disease virus were observed in many strains of these viruses as the basic data for selection of antigens.Antigenic gene products can be used as component vaccine, if one can get them with large quantity. In this research project, antigenic products were obtained using baculovirus vector. Using this vector we could get herpes simplex virus gB like protein of Marek's disease virus, hemagglutinin-neuraminidase antigen of Newcastle disease virus and gA of Marek's disease virus. These proteins were biologically active and may be used as component vaccines.In this research project, we could get many basic data to construct the recombinant vaccines which can be used for veterinary practice.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Nakamura,K.: "A unique region of Marek's disease virusDNA in a virusーnonproductive lymphoblastoid cell line,MDCCーRP1" Jpn.J.Vet.Sci.52. 1341-1345 (1990)
Nakamura, K.:“病毒非生产性淋巴母细胞系 MDCC-RP1 中马立克氏病病毒 DNA 的独特区域”Jpn.J.Vet.Sci.52 (1990)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakamura, K.: "A unique region of Marek's disease virus DNA in a virus-nonproductive lymphoblastoid cell line, MDCC-RP1" Jpn. J. Vet. Sci. 52. 1341-1345 (1990)
Nakamura, K.:“病毒非生产性淋巴母细胞系 MDCC-RP1 中马立克氏病病毒 DNA 的独特区域”Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishino,Y.: "Analysis of the protective effect of the haemagglutininーneuraminidase protein in Newcastle disease virus infection" J.gen.Virol.
Nishino, Y.:“血凝素-神经氨酸酶蛋白在新城疫病毒感染中的保护作用分析”J.gen.Virol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Niikura,M.: "Characterization of haemagglutininーneuraminidase glycoprotein of Newcastle disease virus expressed by a reeombinant baculovirus" Virus Res.
Niikura,M.:“重组杆状病毒表达的新城疫病毒血凝素-神经氨酸酶糖蛋白的特征”病毒研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Highly-reliable IoT platform based on autonomous collaboration of edge cooperation and secure computation
  • 批准号:
    19H04101
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.15万
  • 财政年份:
    2019
  • 负责人:
    SATO Fumiaki
  • 依托单位:
A proposal of a method of securing cloud services based on secret sharing / secure computation and a proposal of safety performance evaluation method
  • 批准号:
    16H02813
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.48万
  • 财政年份:
    2016
  • 负责人:
    SATO Fumiaki
  • 依托单位:
Optimal control method in consideration of the spatiotemporal characteristics of the sensor network with a charging mechanism
  • 批准号:
    25330115
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2013
  • 负责人:
    SATO Fumiaki
  • 依托单位:
Exploration of the new components for elastic fiber assembly
  • 批准号:
    24791181
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.66万
  • 财政年份:
    2012
  • 负责人:
    SATO Fumiaki
  • 依托单位: